Abstract
While antipsychotics are the mainstay of treatment for schizophrenia, many patients do not achieve an adequate response. Indeed, a significant percentage are refractory to medication, including the most effective agent available, clozapine. As a result, there is a need for alternative treatments which are both effective and safe. Therapeutic neuromodulation includes such approaches as electroconvulsive therapy, transcranial magnetic stimulation, transcranial direct current stimulation, and deep brain stimulation and represents a growing field of study for refractory symptoms. This chapter discusses the potential role of such device-based therapies in schizophrenia.
Keywords
- Transcranial Magnetic Stimulation
- Negative Symptom
- Brief Psychiatric Rate Scale
- Motor Threshold
- Left DLPFC
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shergill SS, Murray RM, McGuire PK. Auditory hallucinations: a review of psychological treatments. Schizophr Res. 1998;32(3):137–50.
Kane JM. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview. Br J Psychiatry. 1992;160(17):41–5.
Cerletti U. Old and new information about electroshock. Am J Psychiatry. 1950;107(2):87–94.
Haskett RF, Loo C. Role of psychotropic medications during ECT in the treatment of depression, mania and schizophrenia. J ECT. 2010;26(3):196–201.
Taylor S. Electroconvulsive therapy: a review of history, patient selection, technique, and medication management. South Med J. 2007;100(5):494–8.
Bolwig TG. How does electroconvulsive therapy work? Theories on its mechanism. Can J Psychiatry. 2011;56(1):13–8.
Goswani U, Kumar U, Singh B. Efficacy of electroconvulsive therapy in treatment resistant schizophrenia: a double-blind study. Indian J Psychiatry. 2003;45(1):26–9.
Kupchik M, Spivak B, Mester R, et al. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol. 2000;23:14–6.
Chanpattana W, Somchai Chakrabhand ML. Combined ECT and neuroleptic therapy in treatment-refractory schizophrenia: prediction of outcome. Psychiatry Res. 2001;105:107–15.
Nothdurfter C, Eser D, Schule C, et al. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy. World J Biol Psychiatry. 2006;7(3):162–70.
Suppes T, Webb A, Carmody T, et al. Is postictal electrical silence a predictor of response to electroconvulsive therapy? J Affect Disord. 1996;41:55–8.
Tharyan P, Adams CE. Electroconvulsive therapy for schizophrenia. Cochrane Database Syst Rev. 2005;2:CD000076
Painuly N, Chakrabarti S. Combined use of electroconvulsive therapy and antipsychotics in schizophrenia: the Indian evidence. A review and a meta-analysis. J ECT. 2006;22:59–66.
Matheson SL, Green MJ, Loo C, Carr VJ. Quality assessment and comparison of evidence for electroconvulsive therapy and repetitive transcranial magnetic stimulation for schizophrenia: a systematic meta-review. Schizophr Res. 2010;118:201–10.
Gazdag G, Ungvari GS. Non-pharmacological biological therapies in schizophrenia. Neuropsychopharmacol Hung. 2011;13(4):233–8.
Zervas IM, Theleritis C, Soldatos CR. Using ECT in schizophrenia: a review from a clinical perspective. World J Biol Psychiatry. 2012;13:96–105.
Rosebush PI, Mazurek MF. Catatonia and its treatment. Schizophr Bull. 2009;36(2):239–42.
Makhinson M, Furst BA, Shuff MK, Kwon GE. Successful treatment of co-occurring catatonia and obsessive-compulsive disorder with concurrent electroconvulsive therapy and benzodiazepine administration. J ECT. 2012;28(3):e35–6.
Häßler F, Reis O, Weirich S, Hoppner J, Pohl B, Buchmann J. A case of catatonia in a 14-year-old girl with schizophrenia treated with electroconvulsive therapy. Z Kinder Jugendpscychiatr Psychother. 2013;41(1):69–74.
Rohland BM, Caroll BT, Jacoby RG. ECT in the treatment of the catatonic syndrome. J Affect Disord. 1993;29(4):255–61.
Escobar R, Rios A, Montoya ID, et al. Clinical and cerebral blood flow changes in catatonic patients treated with ECT. J Psychosom Res. 2000;49:423–9.
Girish K, Gill NS. Electroconvulsive therapy in lorazepam non-responsive catatonia. Indian J Psychiatry. 2003;45(1):21–5.
Suzuki K, Awata S, Takano T, et al. Improvement of psychiatric symptoms after electroconvulsive therapy in young adults with intractable first-episode schizophrenia and schizophreniform disorder. J Exp Med. 2006;210:213–20.
Baeza I, Flamarique I, Garrido JM, et al. Clinical experience using electroconvulsive therapy in adolescents with schizophrenia spectrum disorders. J Child Adolesc Psychopharmacol. 2010;20(3):205–9.
Chanpattana W, Sackeim HA. Electroconvulsive therapy in treatment-resistant schizophrenia. J ECT. 2010;26(4):289–98.
Levy-Rueff M, Gourevitch R, Loo H, Olie JP, Amado I. Maintenance electroconvulsive therapy: an alternative treatment for refractory schizophrenia and schizoaffective disorders. Psychiatry Res. 2010;175:280–3.
Kristensen D, Bauer J, Hageman I, Jorgensen MB. Electroconvulsive therapy for treating schizophrenia: a chart review of patients from two catchment areas. Eur Arch Psychiatry Clin Neurosci. 2011;261:425–32.
Chanpattana W, Andrade C. ECT for treatment-resistant schizophrenia: a response from the far east to the UK nice report. J ECT. 2006;22:4–12.
Lerer B, Shapira B, Calev A, et al. Antidepressant and cognitive effects of twice-versus three-times-weekly ECT. Am J Psychiatry. 1995;152(4):564–70.
Charlson F, Siskind D, Doi SAR, et al. ECT efficacy and treatment course: a systematic review and meta-analysis of twice vs thrice weekly schedules. J Affect Disord. 2012;138:1–8.
Chanpattana W, Charabhand MLS, Kitaroonchai W, et al. Effects of twice- versus thrice-weekly electroconvulsive therapy in schizophrenia. J Med Assoc Thai. 1999;82:477–83.
Pompili M, Lester D, Dominici G, et al. Indications for electroconvulsive treatment in schizophrenia: a systematic review. Schizophr Res. 2013;146(1–3):1–9.
American Psychiatric Association Committee on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (A task force report of the American Psychiatric Association). 2nd ed. Washington, DC: American Psychiatric Association; 2001.
Buchannan RW, Kreyenbuhl J, Kelly DL, et al. The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. Schizophr Bull. 2010;36:71–93.
Post A, Keck ME. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanism? J Psychiatr Res. 2001;35:193–215.
Slotema CW, Blom JD, Hoek HW, Sommer IEC. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873–84.
Jasper HH. The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol. 1958;66:376–82.
Geller V, Grisaru N, Abarbanel JM, Lemberg T, Belmaker RH. Slow magnetic stimulation of prefrontal cortex in depression and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry. 1997;21:105–10.
Feinsod M, Kreinin B, Chistyakov A, Klein E. Preliminary evidence for a beneficial effect of low-frequency, repetitive transcranial magnetic stimulation in patients with major depression and schizophrenia. Depress Anxiety. 1998;7:65–8.
Hoffman RE, Boutros NN, Berman RM, et al. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol Psychiatry. 1999;46:130–2.
Hoffman RE, Boutros NN, Hu S, Berman RM, Krystal JH, Charney DS. Transcranial magnetic stimulation and auditory hallucinations in schizophrenia. Lancet. 2000;355:1073–5.
Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations. Arch Gen Psychiatry. 2003;60:49–56.
Hoffman RE, Gueorguieva R, Hawkins KA, et al. Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample. Biol Psychiatry. 2005;58:97–104.
Fitgerald PB, Benitez J, Daskalakis JZ, et al. A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations. J Clin Psychopharmacol. 2005;25(4):358–62.
Hoffman RE, Wu K, Pittman B, et al. Transcranial magnetic stimulation of Wernicke’s and right homologous sites to curtail “voices”: a randomized trial. Biol Psychiatry. 2013;73:1008–14.
McIntosh AM, Semple D, Tasker K, et al. Transcranial magnetic stimulation for auditory hallucinations in schizophrenia. Psychiatry Res. 2004;127:9–17.
Poulet E, Brunelin J, Bediou B, et al. Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia. Biol Psychiatry. 2005;57:188–91.
Chibarro G, Daniele M, Alagona G, et al. Repetitive transcranial magnetic stimulation in schizophrenic patients reporting auditory hallucinations. Neurosci Lett. 2005;383:54–7.
Saba G, Verdon CM, Kalalou K, et al. Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study. J Psychiatr Res. 2006;40:147–52.
Lee SH, Kim W, Chung YC, et al. A double blind study showing that two weeks of daily repetitive TMS over the left or right temporoparietal cortex reduces symptoms in patients with schizophrenia who are having treatment-refractory auditory hallucinations. Neurosci Lett. 2005;376:177–81.
Jandl M, Steyer J, Weber M, et al. Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial. Neuropsychobiology. 2006;53:63–9.
Brunelin J, Poulet E, Bediou B, et al. Low frequency repetitive transcranial magnetic stimulation improves source monitoring deficit in hallucinating patients with schizophrenia. Schizophr Res. 2006;81:41–5.
Rosa MO, Gattaz WF, Rosa MA, et al. Effects of repetitive transcranial magnetic stimulation on auditory hallucinations refractory to clozapine. J Clin Psychiatry. 2007;68(10):1528–32.
Vercammen A, Knegtering H, Bruggeman R, et al. Effects of bilateral repetitive transcranial magnetic stimulation on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophr Res. 2009;114:172–9.
Loo CK, Sainsbury K, Mitchell P, Hadzi-Pavlovic D, Sachdev PS. A sham controlled trial of left and right temporal rTMS for the treatment of auditory hallucinations. Psychol Med. 2010;40:541–6.
de Jesus DR, Gil A, Barbosa L, et al. A pilot double-blind sham-controlled trial of repetitive transcranial magnetic stimulation for patients with refractory schizophrenia treated with clozapine. Psychiatry Res. 2011;188:203–7.
Aleman A, Sommer IE, Khan RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry. 2007;68(3):416–21.
Tranulis C, Sepehry AA, Galinowski A, Stip E. Should we treat auditory hallucinations with repetitive transcranial magnetic stimulation? A meta-analysis. Can J Psychiatry. 2008;53(9):577–86.
Frietas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108:11–24.
Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res. 2012;42:40–5.
Hovington CL, McGirr A, Lepage M, Berlim MT. Repetitive transcranial magnetic stimulation (rTMS) for treating major depression and schizophrenia: a systematic review of recent meta-analyses. Ann Med. 2013;45(4):308–21.
Jardri R, Bubrovszky M, Demeulemeester M, et al. Repetitive transcranial magnetic stimulation to treat early-onset auditory hallucinations. J Am Acad Child Adolesc Psychiatry. 2012;51(9):947–9.
Thirthalli J, Bharadway B, Kulkarni S, Gangadhar BN, Kharawala S, Andrade C. Successful use of maintenance rTMS for 8 months in a patient with antipsychotic-refractory auditory hallucinations. Schizophr Res. 2008;100:351–2.
Tang WK, Ungvari GS. Efficacy of electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: a prospective, open trial. J ECT. 2002;18(2):90–4.
Rado JT. Management treatment of negative symptoms in schizophrenia. Psychopharm Rev. 2011;46(5):33–40.
Cohen E, Bernardo M, Mansana J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry. 1999;67(1):129–30.
Jandl M, Bittner R, Sack A, et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J Neural Transm. 2005;112:955–67.
Sachdev P, Loo C, Mitchell P, Malhi G. Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: a pilot investigation. Psychiatry Clin Neurosci. 2005;59(3):354–7.
Jin Y, Potkin SG, Kemp AS, et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (αTMS) on the negative symptoms of schizophrenia. Schizophr Bull. 2006;32(3):556–61.
Holi MM, Eronen M, Toivonev K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull. 2004;30(2):429–34.
Hajak G, Marienhagen J, Langguth B, Werner S, Binder H, Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol Med. 2004;34:1157–63.
Novak T, Horacek J, Mohr P, et al. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett. 2006;27(1–2):209–13.
Mogg A, Purvis R, Eranti S, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res. 2007;93:221–8.
Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res. 2007;95:151–7.
Goyal N, Nizamie SH, Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J Neuropsychiatry Clin Neurosci. 2007;19:464–7.
Schneider AL, Schneider TL, Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study. Brain Stimul. 2008;1:106–11.
Klein E, Kolsky Y, Puyerovsky M, Koren D, Chistyakov A, Feinsod M. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biol Psychiatry. 1999;46:1451–4.
Fitzgerald PB, Herring S, Hoy K, et al. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul. 2008;1:27–32.
Levkovitz Y, Rabany L, Harel EV, Zangen A. Deep transcranial magnetic stimulation add-on for treatment of negative symptoms and cognitive deficits of schizophrenia: a feasibility study. Int J Neuropsychopharmacol. 2011;14(7):991–6.
Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108:11–24.
Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71(4):411–8.
Guse B, Falkai P, Wobrock T. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review. J Neural Transm. 2010;117(1):105–22.
Guse B, Falkai P, Gruber O, et al. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls—a randomized placebo-controlled, double-blind fMRI study. Behav Brain Res. 2013;237:300–7.
Barr MS, Farzan F, Rajji TK, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry. 2013;73(6):510–7.
Nitsche MA, Baggio PS, Fregni F, Pascual-Leone A. Treatment of depression with transcranial direct current stimulation (tDCS): a review. Exp Neurol. 2009;219:14–9.
Brunelin J, Mondino M, Haesebaert F, et al. Efficacy and safety of bifocal tDCS as an interventional treatment for refractory schizophrenia. Brain Stimul. 2011;5(3):431–2.
Brunelin J, Mondino M, Gassab L, et al. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012;169(7):719–24.
Andrade C. Once- to twice-daily, 3 year domiciliary maintenance transcranial direct current stimulation for severe, disabling, clozapine-refractory continuous auditory hallucinations in schizophrenia. J ECT. 2013;29(3):239–42.
Coffey RJ. Deep brain stimulation devices: a brief technical history and review. Artif Organs. 2008;33(3):208–20.
Plewnia C, Schober F, Rilk A, et al. Sustained improvement of obsessive-compulsive disorder by deep brain stimulation in a woman with residual schizophrenia. Int J Neuropsychopharmacol. 2008;11:1181–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rado, J.T., Hernandez, E.I. (2014). Therapeutic Neuromodulation for Treatment of Schizophrenia. In: Janicak, P., Marder, S., Tandon, R., Goldman, M. (eds) Schizophrenia. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0656-7_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0656-7_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0655-0
Online ISBN: 978-1-4939-0656-7
eBook Packages: MedicineMedicine (R0)